ASX:CSL

Csl Stock Predictions

etoro logo Buy CSL
*Your capital is at risk
$92.59
+0.350 (+0.379%)
At Close: Jun 04, 2026
Currently predicting for Fri, 5 Jun 2026

CSL.AX Prediction Chart

CSL.AX Predictions History

Latest community submissions for CSL.AX.
Predictor Target Session Target Price Result Direction Accuracy Score
Nov 20, 2025 Bullish $178.34 X 0
Aug 20, 2025 $269.55 -0.65% $220.74 V 77.89% 1
Aug 20, 2025 $270.21 -0.41% $220.74 V 77.59% 1
Aug 20, 2025 Bullish $220.74 X 0
May 29, 2025 $245.22 -0.77% $248.00 X 98.88% 1
May 29, 2025 $245.94 -0.48% $248.00 X 99.17% 2
May 29, 2025 Bullish $248.00 V 1
Mar 3, 2025 $262.38 +0.80% $262.00 V 99.86% 6
Mar 3, 2025 $261.60 +0.50% $262.00 V 99.85% 6
Mar 3, 2025 Bearish $262.00 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CSL.AX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CSL LIMITED
CSL
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioede...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE